Clarametyx
PrivateLast Round
Series A
Extension
Aug 4, 2025
Total Funding Raised
$52.99M
Company Overview
Clarametyx Biosciences is a biotechnology company that develops immune-facilitated biologic therapies aimed at combating life-threatening infections by targeting the protective barrier around bacteria to address biofilm-related challenges and reduce antibiotic resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clarametyx Comps
Public and private peers based on sector, stage, and business model.
Clarametyx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Aug 4, 2025 | ||||
| Grant | Jan 7, 2025 | ||||
| Series A | Jan 5, 2024 | ||||
| Grant | Apr 4, 2022 | ||||
| Convertible Debt | Aug 31, 2021 | ||||
Grant | Aug 31, 2021 |
Clarametyx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| Kineticos Ventures | Grant |
| Cystic Fibrosis Foundation | Series A |
| Rev1 Ventures | Seed, Series A |
| Ohio Innovation Fund | Series A |
| JobsOhio | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2025
Douglas Thomson, Venture Partner at KAMRA, joins the board.
- Jan 16, 2025
Developing a novel biofilm disruptor treatment for bacterial infections.
Clarametyx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Clarametyx's valuation, stock price, and market status.
